Monday, October 16, 2017 10:10:36 AM
Now this is based on sales and has nothing to do with the tax credits or selling their operating loses correct?
>>>
The Company expects total revenue for the third quarter ending September 30, 2017 of approximately $915,000, an increase of approximately 95% over the same period in 2016. Based upon the anticipated sales trajectory, the Company believes that it can be sustainably cash flow positive around the end of 2017.
Recent NEPH News
- Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 03/12/2026 08:10:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:01:16 PM
- Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 03/05/2026 12:04:28 PM
- Nephros Expands into Puerto Rico to Deliver Differentiated Water Filtration Solutions Across Medical and Commercial Sectors • GlobeNewswire Inc. • 02/13/2026 01:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:15:32 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2025 11:15:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2025 10:00:38 PM
- Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History • GlobeNewswire Inc. • 11/06/2025 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:01:11 PM
- ¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 10/30/2025 08:00:00 PM
- Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water • GlobeNewswire Inc. • 10/08/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2025 08:09:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:15:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2025 08:39:24 PM
- Nephros Announces Strong Second Quarter Financial Results • GlobeNewswire Inc. • 08/07/2025 08:00:00 PM
- Nephros Schedules Second Quarter 2025 Financial Results Conference Call • GlobeNewswire Inc. • 07/31/2025 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 08:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:15:47 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2025 08:16:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2025 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 08:15:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2025 08:11:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/24/2025 03:13:49 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
